the use of hormones in medical treatment
2 statements, 0 sitelinks - 00:07, 4 June 2023
...lactation/ja|授乳]]、[[Motor coordination/ja|運動]]、[[reproduction/ja|生殖]]、および[[hormone/ja|ホルモン]]によって引き起こされる[[sensory perception/ja|感覚知覚]]。専門は行動内分泌学と[[comparative
...1つのホルモン（[[Thyroid-stimulating hormone/ja|甲状腺刺激ホルモン]]など）が別の二次ホルモン（[[thyroid hormone/ja|甲状腺ホルモン]]など）の作用や放出を制御する。二次ホルモンが多すぎると、一次ホルモンに負のフィードバックを与え、[[homeostasis/j
...
22 KB (746 words) - 20:58, 20 February 2024
...[[:en:contraception|避妊薬]]、[[:en:psychiatry|精神科]]、[[:en:hormone replacement therapy|ホルモン補充療法]]（HRT）、[[:en:anesthesia|麻酔薬]]といった中核的な治療分野に特化している。Organonは国際市場に向けて販
...
6 KB (432 words) - 09:08, 3 January 2024
| name = Therapy
| image = Polio physical therapy.jpg
...
31 KB (4,067 words) - 16:45, 3 January 2023
...ation|movement]], [[reproduction]], and [[sensory perception]] caused by [[hormone]]s. Specializations include behavioral endocrinology and [[comparative endo
...organs, and, conversely, one target organ may be affected by more than one hormone.
...
17 KB (2,368 words) - 13:43, 20 February 2024
...or|GLP-1 receptor]]. They mimic the actions of the endogenous [[incretin]] hormone [[GLP-1]] that is released by the gut after eating.
...ation]] standards of medical care recommend GLP-1 agonists as a first line therapy for type 2 diabetes, specifically in patients with [[atherosclerotic cardio
...
13 KB (1,847 words) - 16:47, 13 April 2024
...ation|movement]], [[reproduction]], and [[sensory perception]] caused by [[hormone]]s. Specializations include behavioral endocrinology and [[comparative endo
...organs, and, conversely, one target organ may be affected by more than one hormone.
...
18 KB (2,440 words) - 13:43, 20 February 2024
...or|GLP-1 receptor]]. They mimic the actions of the endogenous [[incretin]] hormone [[GLP-1]] that is released by the gut after eating.
...ation]] standards of medical care recommend GLP-1 agonists as a first line therapy for type 2 diabetes, specifically in patients with [[atherosclerotic cardio
...
14 KB (1,899 words) - 16:46, 13 April 2024
...[hemostasis/ja|止血]]管理、[[growth hormone/ja|成長ホルモン]]療法、[[Hormone replacement therapy (menopause)/ja|ホルモン補充療法]]にも携わっている。同社は、[[levemir/ja|レベミル]]、[[tresiba/ja|トレシー
...
18 KB (866 words) - 10:32, 21 March 2024
...]]技術と組換えDNA技術の組み合わせは、オーダーメイドの標的医薬品への道を開いた。[[gene therapy/ja|遺伝子治療]]や[[cell therapy/ja|細胞治療]]は新しいアプローチとして台頭してきている。
承認された組換え薬（例えば、[[insulin/ja|インスリン]]、ヒト[[growth hormone/ja|成長ホルモン]]、[[interferons/ja|インターフェロン]]、[[erythropoietin/ja|エリスロポエチン]]、モノクロ
...
24 KB (913 words) - 10:59, 20 March 2024
...]など）、[[gene therapy/ja|遺伝子治療]]、[[Monoclonal antibody/ja|モノクローナル抗体]]、[[cell therapy/ja|細胞治療]]（[[stem cell/ja|幹細胞]]治療など）を含むバイオ医薬品の区別である。その他、作用機序、[[route of admi
医薬品とは、病気の[[Therapy/ja|治療]]や[[cure/ja|治癒]]に使用される[[medicine/ja|薬]]や[[chemical compound/ja|化合物]]の
...
58 KB (1,845 words) - 17:09, 5 November 2023
| treatment = 血圧や血糖値を管理し、コレステロールを下げる医薬品、[[renal replacement therapy/ja|腎代替療法]]、[[kidney transplant/ja|腎移植]]などがある。
...alcium/ja|カルシウム]]、[[phosphorus/ja|リン]]（[[phosphate/ja|リン酸]]）、[[parathyroid hormone/ja|副甲状腺ホルモン]]、または[[vitamin D/ja|ビタミンD]]の代謝に異常を引き起こ可能性のある、ミネラルおよび骨代謝の変化。2) [
...
45 KB (1,204 words) - 00:05, 27 February 2024
| routes_of_administration = [[Subcutaneous injection/ja|皮下]], [[Intravenous therapy/ja|静脈]], [[Intramuscular injection/ja|筋肉]], [[Inhalation administration/ja|
...ともに使用される。[[pregnancy/ja|妊娠]]中の使用は赤ちゃんにとって比較的安全である。インスリンは以前は[[insulin shock therapy/ja|インスリンショック療法]]と呼ばれる精神科治療で使用されていた。
...
69 KB (1,887 words) - 11:33, 22 March 2024
...recombinant therapeutic protein]], and [[living medicine]]s used in [[cell therapy]]. Biologics can be composed of [[sugar]]s, [[protein]]s, [[nucleic acid]]s
...rview |url=https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview |access-date=2017-05-15 |postscript=.}}</ref> W
...
29 KB (3,642 words) - 16:31, 3 January 2023
...er adverse effects. Selective [[thyromimetic]]s that work on the [[thyroid hormone receptor beta]] may be able to exert some of the beneficial [[thermogenic]]
...an to appear. Based on its effectiveness for [[hypothyroidism]], [[thyroid hormone]] became a popular treatment for obesity in [[euthyroid]] people. It had a
...
17 KB (2,406 words) - 18:16, 7 March 2024
...er adverse effects. Selective [[thyromimetic]]s that work on the [[thyroid hormone receptor beta]] may be able to exert some of the beneficial [[thermogenic]]
...an to appear. Based on its effectiveness for [[hypothyroidism]], [[thyroid hormone]] became a popular treatment for obesity in [[euthyroid]] people. It had a
...
18 KB (2,460 words) - 18:15, 7 March 2024
...isease|microvascular complications]]. Combined Metformin and Sulphonylurea therapy did appear to lead to higher risk of [[Hypoglycemia]].
...ntidiabetic drugs cannot be used either under these circumstances, insulin therapy is typically recommended during pregnancy and in liver and [[kidney failure
...
12 KB (1,572 words) - 20:36, 12 March 2024
...dney]]. It is also known as '''1,25-dihydroxycholecalciferol'''. It is a [[hormone]] which binds to and activates the [[vitamin D receptor]] in the nucleus of
The main [[adverse drug reaction]] associated with calcitriol therapy is [[hypercalcemia]] – early symptoms include: [[nausea]], [[vomiting]], [[
...
14 KB (1,940 words) - 21:24, 12 April 2024
...dney]]. It is also known as '''1,25-dihydroxycholecalciferol'''. It is a [[hormone]] which binds to and activates the [[vitamin D receptor]] in the nucleus of
The main [[adverse drug reaction]] associated with calcitriol therapy is [[hypercalcemia]] – early symptoms include: [[nausea]], [[vomiting]], [[
...
15 KB (2,008 words) - 21:20, 12 April 2024
...e/ja|胆汁]]、したがって[[intestine/ja|腸]]に排泄される。HDLコレステロールの副腎、卵巣、精巣への運搬は、[[steroid hormone/ja|ステロイドホルモン]]の合成に重要である。
HDLコレステロール値を上昇させるための[[Pharmacological therapy/ja|薬理療法]]には、[[fibrate/ja|フィブラート]]および[[niacin (substance)/ja|ナイアシン]]の使用が含まれる
...
23 KB (649 words) - 09:26, 10 March 2024